Peer review reports
From: Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression
Original Submission |
17 May 2014 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
Publishing |
26 Feb 2015 |
Editorially accepted |
|
13 Mar 2015 |
Article published |
10.1186/s12885-015-1139-7
|
Learn about peer review